BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2013

View Archived Issues

Novel plasmid-encoded treatment for patients with type 1 diabetes

Read More

Osthole-derived compound has beneficial effects on learning and memory

Read More

Preliminary data presented for the anti-protofibrillar Abeta MAb SAR-228810

Read More

Noscira presents results from the ARGO trial of tideglusib

Read More

Merck Serono presents new agents for autoimmune and inflammatory disorders

Read More

Pfizer reports novel GHR antagonist antibodies

Read More

Allergan discloses new prostanoid receptor antagonists

Read More

New PI3Kdelta inhibitors synthesized at Novartis

Read More

Chinese group patents new Raf kinase inhibitors for cancer

Read More

BeiGene synthesizes novel signal transduction pathway inhibitors

Read More

Bausch + Lomb acquires option to license dry eye syndrome drug

Read More

Ensemble Therapeutics and Alexion to discover macrocycle candidates for rare disorders

Read More

Santarus completes enrollment in CONTRIBUTE study

Read More

NIH awards phase I SBIR grant to Cureveda

Read More

Venaxis' pivotal trial of APPY1 Test passes first of two futility analyses

Read More

EMA committee recommends orphan drug status for Soliris in rare neurological disease

Read More

Alkermes describes new pain, multiple sclerosis and cancer immunotherapy candidates

Read More

FDA approves Janssen's Simponi Aria for treatment of moderately to severely active RA

Read More

Celgene to discontinue phase III trial in elderly patients with B-cell CLL

Read More

Mesoblast receives funds from Australian government for R&D activities

Read More

Cooperative phase IIb trial of MediciNova's MN-166 begins in patients with progressive MS

Read More

Phase III study of Spinal Restoration's Biostat System for low back pain misses primary endpoint

Read More

EMA grants orphan drug status to OXiGENE's Zybrestat in ovarian cancer

Read More

AstraZeneca expands cardiovascular disease pipeline with acquisition

Read More

Kyowa Hakko Kirin files application in Japan to expand indication for mogamulizumab

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing